Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2020.08.17
DATE OF BOARD MEETING
2020.08.10
NOTICE OF THE 2020 THIRD EXTRAORDINARY GENERAL MEETING
2020.08.10
PROXY FORM FOR THE 2020 THIRD EXTRAORDINARY GENERAL MEETING TO BE HELD ON MONDAY...
2020.08.10
RE-ELECTION OF DIRECTORS OF THE FIFTH SESSION OF THE BOARD RE-ELECTION OF SUPERV...
2020.08.04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3...
2020.08.01
RE-ELECTION OF DIRECTORS OF THE FIFTH SESSION OF THE BOARD RE-ELECTION OF SUPERV...
2020.08.01
关于召开2020年第三次临时股东大会的通知公告
2020.08.01
独立董事关于第四届董事会第三十六次会议相关事项的独立意见
2020.08.01
《公司章程》修订对照表
2020.08.01
独立董事候选人声明
第一页
上一页
54
55
56
57
58
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
